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Abstract
The objective of our study was to describe decision making by men and their partners regarding 
active surveillance (AS) or treatment for early-stage, localized prostate cancer. Fifteen couples 
were recruited from a Cancer center multispecialty clinic, which gave full information about all 
options, including AS. Data were collected via individual, semi-structured telephone interviews. 
Most patients were white, non-Hispanic, had private insurance, had completed at least some 
college, and were aged 49–72 years. Ten chose AS. All partners were female, and couples reported 
strong marital satisfaction and cohesion. All couples described similar sequences of a highly 
emotional initial reaction and desire to be rid of the cancer, information seeking, and decision 
making. The choice of AS was built on a nuanced evaluation of the man's condition in which the 
couple differentiated prostate cancer from other cancers and early stage from later stages, wanted 
to avoid/delay side effects, and trusted the AS protocol to identify negative changes in time for 
successful treatment. Treated couples continued to want immediate treatment to remove the 
cancer. We concluded that having a partner's support for AS may help a man feel more 
comfortable with choosing and adhering to AS. Using decision aids that address both a man's and 
his partner's concerns regarding AS may increase its acceptability. Our research shows that some 
patients want to and do involve their partners in the decision-making process. Ethical issues are 
related to the tension between desire for partner involvement and the importance of the patient as 
autonomous decision-maker. The extended period of decision making, particularly for AS, is also 
an ethical issue that requires additional support for patients and couples in the making of fully 
informed choices that includes AS.
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Although there is growing recognition of active surveillance (AS) as a reasonable 
management option for many men with early-stage prostate cancer, it is selected by only 
10% of U.S. men (Andriole et al., 2009). Factors identified as influencing patients’ 
acceptance and adherence to AS are multidimensional and include personal preferences, 
physician recommendation, and the opinions of family and friends (Gorin, Soloway, 
Eldefrawy, & Soloway, 2011; Penson, 2012). Treatment decisions often occur within the 
context of social networks, with patients relying on their partners (e.g., wives, significant 
others) for support and help in making decisions (Emslie et al., 2009; Schumm, Skea, 
McKee, & N'Dow, 2010; Speice et al., 2000; Zeliadt et al., 2011). Partners also play 
important roles in information seeking (Boehmer & Clark, 2001; Davison, Goldenberg, 
Gleave, & Degner, 2003; Echlin & Rees, 2002; Resendes & McCorkle, 2006).
Studies of decisions about the treatment of prostate cancer have concentrated on immediate 
or active treatment options such as prostatectomy, brachytherapy, or external beam radiation 
(Chamie et al., 2012; Zeliadt et al., 2011), In particular, studies that examined decisions of 
couples have rarely included those who have considered active surveillance. Each type of 
treatment for prostate cancer has advantages and disadvantages that may be weighed 
differently by patients and by their partners. For instance, partners tend to be less tolerant of 
uncertainty and most often want to take care of the cancer right away (Davison, Oliffe, 
Pickles, & Mroz, 2009; Holmboe & Concato, 2000). Patients’ partners (e.g., wives) also 
prefer for the patients (e.g., husbands) to receive curative treatment, especially 
prostatectomy, rather than active surveillance, expectant management, or watchful waiting 
(Pickles et al., 2007; Srirangam et al., 2003). In addition, patients and their partners may 
prioritize outcomes differently. Past research shows that patients prioritize quality of life 
while partners prioritize quantity of life when thinking about treatment (Srirangam et al., 
2003; Volk et al., 2004).
Most studies looking at how prostate cancer treatment decisions are made have focused on 
the process between the patient and the health care provider (Davison et al., 2009; 
Ernstmann et al., 2012; Underwood et al., 2010; Zikmund-Fisher et al., 2010). Fewer studies 
have looked at the decision process of patients and their partners (Boehmer & Clark, 2001; 
Schumm et al., 2010; Zeliadt et al., 2011). To the best of our knowledge, no published 
studies have included couples who chose active surveillance as well as couples who chose 
treatment for early-stage, localized prostate cancer. This study describes the decision-
making processes used by a convenience sample of couples who made a decision in a 
multispecialty clinic setting where information about all treatment options, including active 
surveillance, was available. Specifically based on individual interviews with men and their 
partners, we describe their recollections of initial reactions to the cancer diagnosis, their 
information seeking, and the process of making the treatment decision.
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Participants were recruited from the Multidisciplinary Prostate Cancer Clinic (MPCC) at 
The University of Texas MD Anderson Cancer Center. One of the goals of the MPCC is to 
educate men about their management choices based on a thorough assessment of their life 
expectancy, comorbidities, and other medical and psychosocial concerns such as anxiety. 
The clinic schedules a patient for several appointments in a single day with members of a 
multidisciplinary team including a urologist, a radiation oncologist, an advanced practice 
registered nurse, and a medical oncologist as necessary for more aggressive disease. The 
team makes a joint recommendation to the patient about treatment options, including AS. 
Patients make the final decision and are referred to a treatment team or to an AS protocol.
This article is based on a subsample of a larger qualitative study. MPCC patients who were 
eligible to participate in our study were: 1) diagnosed with localized prostate cancer, defined 
as cancer that had not spread beyond the prostate gland at the time of diagnosis, 2) English 
speaking, and 3) had a partner who was willing to participate in the study and to be 
interviewed separately. Patients were sampled to include those who selected AS or 
immediate treatment (T). The AS patients had no evidence of more aggressive disease on re-
biopsy prior to initiating AS (a requirement of the AS protocol) and were within 6–18 
months of their decision to be on the AS protocol. This time frame was selected because few 
men would have transitioned to active treatment due to disease progression, yet all would 
have several months’ experience with the AS protocol, including returning for surveillance 
testing. Treated men had chosen some form of surgery or radiation and were within 6–18 
months of completing treatment (the date of surgery or completion of a course of radiation) 
so that the acute recovery period would be over and most patients would have achieved 
continence.
An advanced practice registered nurse confirmed the eligibility of men based on review of 
medical records and contacted them about participating in the study. Of the 36 men who 
were contacted, 30 agreed to participate in the larger qualitative study. Men were asked if 
they were in a relationship (i.e., married or involved with someone they consider their 
partner) and, if yes, for permission to contact this person. This study of couples was limited 
to 17 men with partners who were also willing to participate. However, two couples were 
excluded from the analyses because the men were not offered AS, resulting in a study 
sample of 15 couples.
The project was reviewed and approved for use with human participants by the Institutional 
Review Board of The University of Texas MD Anderson Cancer Center and the Committee 
for the Protection of Human Subjects at The University of Texas School of Public Health..
Measures and interview procedures
A research coordinator scheduled men and their partners for separate telephone interviews, 
which took place between May and August 2011. All interviews were conducted by RV 
(health services researcher), YL (psychologist), or a research assistant. No interviewers had 
prior relationships with the patients. Interviewers telephoned most participants at home, 
Le et al. Page 3













asking them to take the call in a private setting away from their partners. Participants were 
questioned by interviewers of the same sex, and the interviews were audio-recorded and 
transcribed. Each participant received $50.00 as compensation.
Interviews were scheduled for one hour and included an informed consent process, close-
ended questions about social characteristics, relationship attributes, and information about 
the treatments received, followed by semi-structured questions about the participants’ 
decisions. The close-ended questions assessed: 1) age; 2) education; 3) race/ethnicity; 4) 
household income; 5) which treatment options, including active surveillance, had been 
offered; 6) which treatment option was selected; 7) the role each member of the couple 
played in the treatment decision; and 8) the couple's adjustment and coping. We used 
modified items from the Control Preferences Scale (Degner et al., 1997) to measure the 
participants’ perceptions of the decision-making role that each member of the couple took in 
the treatment decision. Responses ranged from “preferred to make the decision on the 
patient's own,” to “shared equally in decision making,” to “preferred that the partner make 
the decision.” Dyadic adjustment was measured using the 14-item Revised Dyadic 
Adjustment Scale with dyadic consensus, dyadic satisfaction, and dyadic cohesion (Busby, 
Christensen, Crane, & Larson, 1995). Sample items included “How often do you and your 
partner quarrel?” and “How often do you and your partner engage in outside interests 
together?” Responses ranged from “all the time” to “none of the time.”
The semi-structured part of the interview included questions about the treatment options 
offered to the patient, how the patient and partner discussed and considered the choices, and 
how the respondent would describe AS. For example, we asked, “Could you tell me in your 
own words what active surveillance is all about?” We also asked about sources of 
information consulted—for example, whether patients or partners made use of the Internet, 
books, and other written materials or talked with others who have prostate cancer—what 
role each member of the couple played in making the treatment decision, and whether 
members of couples selecting AS had seen any pressure from others to consider immediate 
treatment. Questions were also included about the importance of specific treatment-related 
side effects (i.e., impotence, urinary incontinence, and bowel incontinence) and other 
quality-of-life issues that might have been related to the treatment choice.
The interviews concluded with a question about lessons for other patients and partners who 
are facing similar treatment decisions. Interviews lasted between 20 and 65 minutes. During 
the period when the interviews were being conducted, interviewers met weekly and 
discussed participants’ responses and the similarities and differences in responses across 
participants. Based on the discussion, minor modifications were made to the interview 
schedule to improve the elicitation of respondents’ accounts of decision making, but the 
questions remained essentially the same.
Data analysis
The analysis was conducted by four of the authors (TB, YL, PDM, SM), none of whom had 
a prior relationship with the study participants. We used the couple as the unit of analysis in 
identifying thematic patterns (Braun & Clarke, 2006) for the 15 patient-partner dyads. All 
interviews were reviewed independently by all analysts to identify broad themes. A coding 
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table was then devised with three main themes: 1) initial reactions to the diagnosis, 2) 
information seeking, and 3) making the decision. Each interview was then re-read and coded 
by at least two analysts. Disagreements in coding were resolved by discussion among all 
analysts. We looked for overlaps and contrasts across the individual accounts of the decision. 
Joint consideration of the answers of each partner added information and allowed us to 
identify areas of agreement or divergence within each couple (Eisikovits & Koren, 2010). 
Analyses also compared couples in which the man chose AS with those who chose 
immediate treatment. For the sample description, we compared the percentages in AS and 
treated groups. Although the sample size was not adequate for quantitative analysis, the 
purpose of the comparison was to provide information about the perceived quality of 
relationships in interviewed couples. We do not consider this a true mixed methods study 
because the sample size was too small for quantitative analysis.
Results
Ten men were being followed on an AS protocol and another five had completed treatment 
(T) (Table 1). Patients were somewhat older than their partners. Most participants had at 
least some college and were white. All partners were female and were married or viewed 
themselves in a marriage-like relationship (we will refer to all as “partners“ regardless of 
marital status). Overall, couples reported high dyadic adjustment, finding their marital 
interactions satisfying and their relationships cohesive. Dyadic adjustment scores did not 
appear to differ between AS couples and treated couples. The majority of the couples 
perceived the decision making to be collaborative, although patients were more likely to 
describe shared responsibility and partners to say that the patient had made the decision after 
considering the partner's point of view. Six patients (5 AS, 1 T) reported making the decision 
themselves. Four patients said that they had made the decision after considering their 
partner's opinion (2 AS, 2 T), and five said that the decision was a shared responsibility (3 
AS, 2 T). Men choosing AS were more likely to say that they had made the decision 
themselves than were men choosing active treatment. A larger proportion of partners in the 
T group (80%) than in AS (40%) said that the patient made the decision after seriously 
considering the partner's opinion (4 AS partners, 4 T partners).
Guided by the interview structure, both AS and T couples described their interactions in 
three periods: initial diagnosis, information seeking before and after enrolling as patients in 
the MPCC, and making the decision. Our analysis focused on their accounts of their 
decision-making process as well as advice that they would give to other couples. We identify 
quotations with an arbitrary couple number, with H for patient/husband and W for partner/
wife, AS for active surveillance and T for treatment.
Initial reactions to the diagnosis
Some men had had a biopsy following an elevated or rising PSA test. Others received a 
biopsy in conjunction with treatment for a urologic condition. The initial news of the 
diagnosis took place in the office of a community-based urologist who communicated the 
biopsy results and presented information about treatment options. All respondents 
characterized the session as presenting a lot of information to be absorbed at a time of 
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heightened emotion. One partner explained, “not only are you told that you have cancer, but 
now you're being presented with so many options. So it is a lot to digest at one time” (3W, 
AS). Her husband expressed his reaction in this way: “I just heard the word ‘cancer’ and that 
was serious enough right there, so I was figuring I would get rid of it” (3H, AS). In a similar 
summary, a man treated with proton radiation told us, “My first thing was to get it out of 
there” (8H, T). His partner said, “We wanted to be aggressive with it and to put a stop to it” 
(8W, T). We see the heightened emotion expressed in statements about the importance of 
getting the cancer out of the body.
Even more than a year after diagnosis, the couples’ accounts were highly expressive. One 
partner summarized her experience in this way: “When you hear the word ‘cancer,’ the first 
thing you think of is getting rid of the cancer.” She contrasted it with their later reactions, 
“. . . when we became more informed, we realized there were more options” (1W, AS). In 
the discussions about their initial reaction to the diagnosis, couples were in agreement about 
what had occurred and about how they had reacted to the news. This convergence was seen 
in both treated and AS couples.
We saw divergence, however, in the views of AS and treated couples regarding lessons they 
had for other couples facing this decision. The AS couples, both men and their partners, 
counseled the importance of not getting too upset, of staying calm and not succumbing to 
panic. This was coupled with the message not to rush into a choice, that there is “no need to 
run off and get treatment” (29H, AS). Although they may not have initially reacted in this 
way, it is the advice they wished to convey to others facing a similar decision. Their 
recommendations indicated that their perspectives on the sense of imminent threat had 
changed over time and that some men had changed faster than their partners. For treated 
couples, the sense of urgency did not change.
Information seeking
Couples in this study, none of whom made a treatment decision in the session in which they 
learned of the diagnosis, began an information-seeking phase that lasted from two weeks to 
several months. During this time, couples often sought information from the Internet, 
physicians, support groups, and friends and family members who had experienced cancer. 
Generally, they sought information from multiple sources. AS and treated couples provided 
similar descriptions of the process of information seeking, although they differed with 
respect to their relative emphasis (or lack of emphasis) on AS. Some AS couples spent a 
longer time in the information-seeking phase because they lived in places where AS was not 
readily available, and they had to actively seek out and travel to treatment centers offering it 
as a treatment option.
Both men and their partners reported that the partner was involved in information seeking. 
One exception was a treated couple in which the man enlisted his brother in his research on 
prostate cancer; however, he did discuss what he found with his wife. Respondents often 
described playing a specialized role in information seeking based on such skills as facility 
with computers and the Internet, processing or understanding statistical or scientific 
information, or note taking and organizing information. Another specialized skill was 
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networking with friends and community members to learn about the experiences of others 
who had been treated for prostate cancer.
Making the decision
In general, patients described their partners as being very involved in decision making. 
Similarly, partners described themselves as having been very involved in making the 
decision regarding the patients’ treatment choice: that is, we heard much “we” talk in 
discussions of the decision. This is consistent with findings from the close-ended question 
about the role the partners played (see table 1). Both AS and treated couples described the 
decision as being ultimately up to the man, as the person with cancer. As one partner said, 
“We agreed that whatever he decided on, that we would do it as a team” (10W, AS). Another 
partner summarized, “We went to all the doctors together, got all the information together 
and then we would discuss it, but the ultimate decision was his” (8W, T). Although both the 
men and their partners talked about the importance of partner involvement, partners provided 
more detailed accounts of how they participated.
The decision for treatment or AS is one of fundamental trade-offs. For localized prostate 
cancer the difference in terms of benefit in survival is small, and all the active treatments 
present the risk of side effects including impotence and urinary incontinence. AS and treated 
couples evaluated the trade-offs differently.
Selecting AS—The AS couples tended to move quickly to a position of reconsidering the 
gravity of this cancer diagnosis. This process took a variety of forms, which were often 
combined. For example, at a general level, couples would refer to prostate cancer as being a 
condition that a man dies with, rather than dies from, or would emphasize that prostate 
cancer is frequently a slow-growing or less aggressive type of cancer. Regarding their 
specific situation, they characterized the cancer as being “low grade,” referring to the 
Gleason scores of the biopsy samples. The men, in particular, numerically described their 
biopsy results in a fashion that pointed out that their condition should not be seen as highly 
risky. As one man described his results, “of the 12 samples, there were cancer cells found in 
only 5% of the tissue in one of the 12 samples” (17H, AS). His partner echoed that language 
in referring to “the minor part of the biopsy that was cancerous” (17W, AS).
The AS couples also considered the possible side effects of active treatment (i.e., urinary 
incontinence, fecal incontinence, sexual dysfunction) when making a decision. The men, and 
sometimes the partners, discussed the importance of avoiding treatment-related side effects, 
As one man said,
Well, the advantages are not having to worry about incontinence and sexual 
dysfunction. I feel fine. My health is—if it weren't for the biopsy, I would have no 
way of knowing that I have cancer because my health is excellent, and it just 
seemed to me that why endure these side effects of treatment when if I—as long as 
I'm keeping a close eye on it with my doctors, I can possibly prolong this for a 
number of years. (12H, AS)
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Similarly, his partner talked about the patient's desire to avoid side effects and her 
conclusion that the low-risk features of his condition would permit him to avoid the risk of 
side effects:
Well, the advantages were that he wouldn't have to have the surgery, of course, and 
the recovery from that. And he was concerned about incontinence and things like 
that with surgery, or even with the radiology. So it felt like this was a good thing for 
him with his low scores and just the one sample having cancer. (12W, AS)
The acceptance of AS was also supported by the couples’ confidence in it as a system of 
regular surveillance activities. One partner defined the AS program as a “regimen of testing 
at periodic times to make sure that the amount of cancer has not grown. Keeping on top of 
his situation so that if anything gets worse, then he can choose a different treatment” (1W, 
AS). Several important elements are expressed in that remark. First, that AS is not just 
waiting, but being tested at specific times and using the results to judge how the man's 
condition has changed. This statement also echoed the position that there would be 
additional opportunities to choose to be treated, and that they would not have missed their 
chance at effective treatment by waiting. Because AS was presented as a system with a 
defined protocol, the couple do not feel as if they are alone in the decision but that they are 
supported by the monitoring and the structured opportunities to evaluate the man's condition 
and life circumstances. Having learned that the risk was smaller than first perceived, that the 
couple would have support in monitoring the man's condition in the AS protocol, and that 
there would be additional opportunities to opt for treatment, provided support for the 
decision for AS. One wife said, “If we ended up with not so great numbers or yucky dirty 
looking biopsies, he agreed to come off study [AS protocol] and have it removed” (16W, 
AS).
Selecting immediate treatment for prostate cancer—The couples who ultimately 
chose treatment faced the same central trade-offs. Unlike AS couples, they continued to 
emphasize the importance of getting the cancer out, to have a cure and to be done with the 
process. Both men and their partners articulated the risks of side effects from treatment but 
considered them secondary to eradicating the cancer:
We knew about the side effects—about the erectile dysfunction and about the 
bladder control issue. But, to me, those were only secondary problems; they could 
be overcome. You can always make adjustments in your life to overcome those or 
adjust to them. Our main factor was his survival rate. (27W, T)
A man treated with robotic surgery summarized,
The urinary incontinence was probably the biggest concern that I had, followed by 
the sexual side effects. But bottom line is, having surgery, being alive, being viable
—overrode all of those concerns . . . If the surgery is a success, and I'm going to 
live, then I'll deal with the other issues. (23H, T)
In general, these couples described making a decision among various treatments, rather than 
between AS and one or more treatments. For example, in describing treatments, they related 
them to features of their own lives; the man quoted above described himself as being young 
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and able to recover from surgery, while other men cited their ages or other health conditions 
that would make surgery more risky. Other men, particularly those still employed, did not 
want to take on a radiation treatment regimen stretching over weeks.
The idea of keeping the decision open, of being able to delay having treatment, which 
appealed to the AS couples, was not attractive to the couples who chose treatment. They 
were selecting a “final” solution. As one partner said, “They told us about it [AS] but I said 
that we did not want to wait. We did not want him to have cancer anymore. And the thought 
of waiting to see if it was going to spread more rapidly was not an option for us. We couldn't 
deal with that. We wanted him well” (21W, T).
Discussion
This study describes couples’ recollections of their initial reactions to the diagnosis of 
prostate cancer, their information seeking, and the process of making the treatment decision 
for early-stage, localized prostate cancer at a multispecialty treatment clinic. What is unique 
about our study is the inclusion of couples who selected AS, because partners have generally 
not been supportive of AS (Penson, 2012; Schumm et al., 2010). We found that the decision-
making process of these couples, resulting in the man choosing AS, shared similarities with 
that of couples with the man choosing treatment. In line with previous studies of treated 
couples (Zeliadt et al., 2011), we found that partners of men who chose AS and treatment 
often attended clinic visits and were involved in discussing treatment options with their 
husbands and with providers. Partners of men who chose AS as well as those of men who 
chose treatment were also often involved in information seeking (Davison et al., 2009; 
Srirangam et al., 2003).
In this sample, most men and their partners were in agreement about the partner's level of 
involvement in the information-seeking and decision-making process. Couples in the 
treatment (T) group generally reported that the final decision was shared or was the man's to 
make, after seriously considering his partner's opinion. This finding was in line with other 
studies of treated couples (Schumm et al., 2010; Srirangam et al., 2003; Zeliadt et al., 2011).
So how did partners come to support the patient's decision about AS? We know that AS is 
not a common choice. In fact, when Srirangam and colleagues (2003) asked partners about 
their treatment preferences, none of the 82 partners surveyed chose AS. Couples choosing 
AS found that the presence of the AS protocol was reassuring. They saw that the protocol 
would provide systematic and close monitoring of the patient's condition. This increased 
their comfort with selecting AS, particularly among the partners. As in other studies (Volk et 
al., 2004), the partners were more concerned about maximizing the man's length of life than 
about possible side effects, but once the AS protocol was understood, the AS partners were 
willing to accept that with this particular cancer, and given their husbands’ early-stage 
disease, AS would be a viable option. In this study, some AS partners described how they 
were at first reluctant to select AS, but then moved to supporting their husbands’ decisions 
after information seeking and discussion. The couples choosing treatment were also 
informed about the AS protocol, but did not select it because they felt it important to remove 
the cancer as soon as possible.
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This study has both strengths and limitations. One strength is that all of the men surveyed 
were drawn from the same clinic population and were all offered both AS and immediate 
treatment by relevant specialists in a balanced way on the same day. They were also able to 
discuss treatment options and to consult with a variety of specialists, a benefit available to 
those receiving treatment in a multidisciplinary prostate cancer clinic. While primary care or 
urology clinics may encourage patients to seek second opinions, they are not able to offer 
the convenience in scheduling of multidisciplinary consultations that is available at the 
MPCC. In this clinical setting, some men and their partners changed their view of the 
immediate threat of cancer, and of the need to be treated immediately, and selected AS. 
However, the lack of availability of multidisciplinary clinics outside of academic centers and 
large metropolitan areas may limit the number of men who will have access to this resource.
Other limitations of this study include the homogeneity of the participants (i.e., mostly 
white, highly educated, privately insured), and high dyadic adjustment of these couples. 
There were limitations in the qualitative analysis method. The analysis was mostly 
conducted following the completion of data collection so that lessons from the data could 
not guide decisions such as whether theoretical saturation had been reached. The small 
sample size may also be seen as potentially limiting the conclusions reached. These factors 
may limit the generalizability of our findings. Nevertheless, participants’ perspectives 
suggest messages that may be helpful in bringing AS into more serious consideration.
One of the ethical issues raised by this study concerns the principle of the patient as an 
autonomous decision-maker. The patients studied wanted to involve their partners, and 
physicians have viewed this as important in making decisions about prostate cancer. 
However, although our study participants were generally concordant in their preferences for 
shared decision making, not all couples may agree. Ethical issues may arise in cases where 
partners want to be more involved in the decision-making process than is wanted by the 
patients. In these circumstances, the patient's care team may need to advocate for his wishes 
and provide him with additional support. Providers will need to consider how to provide 
information for both patient and partner while clarifying that the choice is the patient's.
A second ethical concern is the conditions under which information is provided, such that 
the full range of alternatives, including AS when appropriate, is described. Our study shows 
that the decision-making process is lengthy. The extended period of information seeking 
used by couples selecting AS suggests that a single encounter in which the physician 
outlines features of the diagnosis and prognosis may not be adequate. The cancer center 
multispecialty clinic provided a thorough and balanced opportunity to explore features of 
both treatment and AS. However, since this setting is not available to all, some alternative 
support must be developed. Designing educational and value clarification materials that can 
be used by couples in conjunction with physicians and other providers is one way to address 
the ethical issues of fully informed decision making. Providers may need to check in 
periodically with the patient to see whether he is still comfortable with including the partner 
in office visits and decision making.
Given that partners are often less accepting of AS as a treatment option for men with 
localized prostate cancer (Penson, 2012; Srirangam et al., 2003) and are influential in men's 
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treatment decision making, our study adds to the literature by describing how couples who 
do decide on AS make that decision. Further research including men and their partners from 
different ethnic and socioeconomic groups and those from a variety of practice settings (e.g., 
private clinics and federally qualified health centers for underserved populations) would be 
informative. Men who are considering AS may require additional support from their care 
team to better communicate their choice of AS to partners as well as to other family 
members. Health care providers could perhaps structure office visits so that patients and 
their partners have ample opportunities to discuss treatment options with the provider and 
with each other. In addition, the development of decision aids that might be effective in 
helping men and their partners understand that not all types of cancer need to be treated 
immediately would be useful. These decision aids might be developed to help men 
personalize their own risk, as well as to discover their values and their partner's values 
related to treatment, side effects, and their tolerance for the systematic protocol of AS. It 
may also be beneficial to design decision aids for the partners of men who are eligible for 
AS. These decision aids for couples could frame messages about AS in terms of the benefit 
of maintaining both the man's quantity and quality of life as well as the reversibility of the 
decision when symptoms appear or worsen.
In summary, our study provides a glimpse into the decision-making processes of couples, 
including those who choose AS. Although some partners place great value on the removal of 
cancer through immediate treatment, they recognize that the ultimate decision lies with the 
patients. Decision aids that address both patients’ and partners’ concerns could help couples 
to better cope with the decision-making process.
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Table 1
Characteristics of Men and Partners
Men (Patients) n=15 Partners n=15
Treatment
    Active Surveillance 10
    Radiation 3
    Surgery 2
Age
    Mean (SD) 61.5 (7.5) 59.3 (7.0)
    Minimum, Maximum 49, 72 45, 71
Education
    High school graduate or less 3 2
    Some college or college graduate 6 10
    Postgraduate education 6 3
Decision Role
*
    Preferred man to make treatment decision 6 3
    Man made decision after considering partner's view 4 8
    Shared responsibility for decision 5 1
    Partner made after considering the man's view 0 1
Dyadic Adjustment
    Mean (SD) 52.47 (5.16) 52.82 (4.08)
Note: RDAS cutoff score for non-distressed couples is >48.
*
Missing data from 2 partners on decision role.
Narrat Inq Bioeth. Author manuscript; available in PMC 2017 January 01.
